TSVETKOVA, VASSILENA

TSVETKOVA, VASSILENA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary 2018 Miglietta, FedericaTsvetkova, VassilenaDieci, Maria VGuarneri, Valentina + FRONTIERS IN ONCOLOGY - -
Immune characterization of breast cancer metastases: Prognostic implications 2018 Dieci, Maria VittoriaTSVETKOVA, VASSILENAGriguolo, GaiaMiglietta, FedericaCappellesso, RoccoVernaci, GraziaTasca, GiuliaConte, PierfrancoGuarneri, Valentina + BREAST CANCER RESEARCH - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 2020 Di Liso, ElisabettaBottosso, MicheleTsvetkova, VassilenaDieci, Maria VittoriaMiglietta, FedericaTasca, GiuliaGiorgi, Carlo AlbertoGiarratano, TommasoMioranza, EleonoraDei Tos, Angelo PaoloConte, PierFrancoGuarneri, Valentina + ESMO OPEN - -
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy 2020 Dieci M. V.Tsvetkova V.Griguolo G.Miglietta F.Tasca G.Giorgi C. A.Cumerlato E.Massa D.Orvieto E.Guarneri V.Conte P. + EUROPEAN JOURNAL OF CANCER - -
Erbb2 mrna expression and response to ado-trastuzumab emtansine (T-dm1) in her2-positive breast cancer 2020 Griguolo G.Tsvetkova V.Giarratano T.Dieci M. V.Conte P.Guarneri V. + CANCERS - -
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 2020 Miglietta F.Dieci M. V.Tsvetkova V.Griguolo G.Vernaci G.Menichetti A.Faggioni G.Giarratano T.Mioranza E.Genovesi E.Cumerlato E.Bottosso M.Conte P.Guarneri V. + THE ONCOLOGIST - -
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 2021 Dieci M. V.Griguolo G.Bottosso M.Tsvetkova V.Giorgi C. A.Vernaci G.Tasca G.Genovesi E.Cumerlato E.Conte P. F.Guarneri V. + NPJ BREAST CANCER - -